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Summary Breast cancer incidence in Sweden during the period 1984-93 shows no clear trend in women aged below 40 years but a
transient increase at ages 50-69 years, probably as a result of mammography screening. Our data give no indication that use of oral
contraceptives or replacement hormones have affected nationwide breast cancer incidence rates.
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The occurrence ofbreast cancer has been increasing worldwide in
high-incidence Western countries as well as in low-incidence
Asian countries (Quinn and Allen, 1995). Both in Scandinavia
(Ewertz and Carstensen, 1988; Persson etal, 1993) and in the USA
(Holford et al, 1991), secular trends were linked to birth cohorts,
indicating that exposure to important (but not well-characterized)
risk factors has changed over generations. A recent analysis of
breast cancer incidence from the Surveillance Epidemiology and
End Results Program (SEER) in the USA during the period
1989-93 demonstrated among women aged 40 years and older a
pronounced increase for in situ and localized tumours but a drop
for regional cancers, a pattern probably due to the introduction of
mammography screening (Chu et al, 1996). In a previous analysis
of nation-based breast cancer incidence rates in Sweden during
1958-88, we found an average annual increase in the age-
standardized rates of 1.3% (Persson et al, 1993). Although present
in all age groups, this increase was most rapid among younger
women. The rate of increase, however, slowed down towards the
end of the study period, particularly among the youngest and
oldest women. Birth cohort analyses revealed a more than twofold
higher risk among women born in the 1940s compared with those
born in the 1880s.
A recent report from Norway - where there has been little
mammographic screening - showed a substantial increase in
breast cancer incidence during the period 1983-1993, which was
confined to women aged below 50 years (Matheson and Tretli,
1996); the annual increases were 4.0%, 1.1% and 0.5% at ages
0-49, 50-59 and 60-69 years respectively. There was no evident
change in the stage distribution over time. The authors suggested
several possible causal factors in Norwegian women born after the
Second World War, such as changes in lifestyle, especially during
adolescence, delayed reproduction and increased early use of
combined oral contraceptives.
The recent findings in Norway and the USA prompted us to
update our earlier analysis of trends in breast cancer incidence in
Sweden. In particular, we have explored recent changes in cancer
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incidence that might be due to the implementation of mammog-
raphy screening programmes in the late 1980s, to extensive use of
combined oral contraceptives (COCs) in young women or to
increasing use of hormone-replacement therapy (HRT) among
post-menopausal women.
SUBJECTS AND METHODS
A nationwide cancer registry has operated in Sweden since 1958.
In the majority ofcases, the registry receives reports on diagnosed
cancers from the responsible clinician as well as the pathologist or
cytologist. Under-reporting of data to the registry has therefore
been low, in the 1970s estimated at 5% (Mattsson and Wallgren,
1984) and in recent years at about 2% (CancerRegistry, 1996). For
98% of the breast cancer cases registered in 1993, the diagnosis
was based on a histopathological examination; a similarly high
figure was recorded during the last decade. In 1993 no cases were
diagnosed at autopsy only (in previous years this figure was less
than 0.6%).
We based this updated analysis on all 50 022 cases of invasive
breast cancer (ICD7 code 170) reported during a 10-year period
from 1984through 1993 (covering the lastyearwithpresently avail-
able statistics). The chosen period partly overlapped the previous
studyperiod(1958-88) andcoincided, exceptfor 1 year, withthatof
the Norwegian investigation (Matheson and Tretli, 1996).
Statistical methods
We analysed the trendwise development in individual age groups
using models, assuming that the natural logarithm ofthe incidence
was a function of time. We used both linear models and models
including aquadratic (trend) term. While the linear models assume
a constant growth rate in incidence, the second-order polynomial
models allow a non-linear development of a certain kind.
Although the second-order model may not give a completely accu-
rate description ofthe trendwise development, it makes it possible
to test whether allowing a specific type of non-linearity improves
the linear model. A more detailed picture ofthe trends is given in
graphs for 10-year age groups. A P-value (two sided) of 0.05 or
lower was considered to be statistically significant. Age-standard-
ized rates were calculated using the Swedish population in 1970.
167168 I Persson etal
400
I
98
-
s.1
I
300
200
100
0
...,...i...^.......................................... *.
b. ,, , >,'''/'1.!.,....................................,./..s.'.';.........r
.a_*,-*- ,. ,9-'.-sF--g-gae+ ,..:._'lv
.,, '' T
,,.: .. ..
+-_--+'' .. '*-,,v@f__s-w@4
*'---'-t_'__'__
., ,, ,, ,.. ^
.1984 1919 1861 tS97 1 .1 i 1=1 19
Figure 1 Incidence of breast cancer in Sweden 1984-93. Number of new
cases of breast cancer per 100 000 women, by 10-year age groups and age
standardized (to the Swedish population in 1970). -L-, 0-39 years; --A--,
40-49 years; - -+- -, 50-59 years; - -0- -, 60-69 years; - -x- -, 70-79 years;
-, 80-99 years; -- -, age standardized
RESULTS
Figure 1 demonstrates the trends in breast cancer incidence by age
groups. The age-standardized breast cancer incidence increased
from 91 per 100 000 women-years in 1984 to a maximum of 115
in 1990, thereafter diminishing to 104 per 100 000 in 1993.
Women under the age of 40 years had no notable change in
incidence over time. In contrast women aged 40-49 years had a
seemingly steady increase from the late 1980s. Among 50 to
69-year-old women, we observed a substantial increase from the
late 1980s followed by a decline in the early 1990s. For women 70
years and older, no clear patterns were noted.
Further analyses using linear models demonstrated an average
annual increase in the age-standardized rate of 2.1% (95% confi-
dence interval 0.9-3.3) (Table 1). The second-order term in the
non-linear model was significant (P = 0.04) with a negative sign,
confirming the non-linear development - an early increase
followed by a decrease - in the age-standardized rate. The age-
specific analyses showed no clear trends among women below 40
years of age, as reported in Table 1. For the aggregated group of
women aged below 40 years, the annual age-standardized change
was -1.4% (95% CI -2.7-0.0). In contrast, there was a significant
increase for all 5-year age groups between 40 and 69 years.
We noted a particularly pronounced increase among women
50-69 years of age, with average annual increments of 3.3% to
4.3%. In these age groups, the most rapid increase started a few
years into the 10-year study period, with indications ofdecreasing
trends towards the end of the period (Figure 1). For women aged
55-69 years, the latter trends were supported in the modelling
allowing for nonlinear effects, with negative but statistically non-
significant second-order terms (P = 0.07-0.15). Among women 70
years orolder, we found no clearpattems, except for the age group
70-74 years in which there was a marked non-linear trend, an
initial increase followed by a later decline.
DISCUSSION
Our analysis revealed three notable patterns: (1) compared with
the 31-year period 1958 through 1988, the average annual rate of
increase (age-standardized) was somewhat higher, 2.1% vs 1.3%;
(2) women below age 40 years showed no clear change in inci-
dence (ifanything a tendency towards a decrease), whereas in the
previous study a declining rate ofincrease was found; and (3) most
importantly, women aged 40-69 years showed a pronounced but
seemingly transient rise from the late 1980s.
A comparison of contemporaneous breast cancer incidence
patterns in Norway and Sweden is potentially informative. In
contrast to Sweden, the Norwegian data, unaffected by mammo-
graphic screening, indicated a4% annual increase in the incidence
for women below 50 years of age. We found little change in the
Table 1 Trends in age-specific and age-standardized breast cancer incidence rates in Sweden 1984-93
Age (years) Linear model Model including a quadratic-trend term
Annual P-value Sign of the P-value of the
change in % second-order term second-order term
25-29 -4.6 0.25 + 0.24
30-34 0.0 0.99 + 0.89
35-39 -1.2 0.39 0.35
40-44 1.8 0.04 0.74
45-49 2.0 0.005 0.22
50-54 4.3 0.001 + 0.94
55-59 3.5 0.007 - 0.07
60-64 3.3 0.007 - 0.15
65-69 4.0 0.014 - 0.10
70-74 0.4 0.64 - 0.004
75-79 -1.6 0.012 - 0.57
80-84 1.0 0.06 - 0.54
85- -1.4 0.08 + 0.25
Age standardized 2.1 0.004 0.04
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incidence for women below 40 years, but a slight (up to 2%) rise in
women aged 40-49 years of age. The absence oftrends among the
youngest women in Sweden contradict the trend in Norway being
caused by oral contraceptives (Matheson and Tretli, 1996). As
these have been used at least as extensively in Sweden (Lund et al,
1989), their risk-increasing effect, which appears to be transient
(Collaborative Group, 1996), should therefore be the most marked
at young ages. Moreover, trends in fertility patterns and exposure
to other established risk factors for breast cancer are probably
similar in the two countries - except for factors linked to birth
cohorts that were adolescent during the Second World War (Tretli
and Gaard, 1996).
In Sweden, the estimated proportion of hormone replacement
therapy (HRT) users in perimenopausal age groups was 20% in the
late 1980s (Lindgren et al, 1993) compared with less than 10% in
the late 1970s (Persson et al, 1983). However, the possible link
between HRT and breast cancer risk is rather weak, with relative
risk estimates of 1.5-2, and the risk relationship seems to be
limited to exposure exceeding 6-10 years (Brinton and Schairer,
1993). Therefore, HRT is not likely to be an important explanation
for the observed population trends.
Rather, we believe that mammographic screening - proven to be
sensitive in women at ages above 50 years (Nystrom et al, 1993) -
provides the most plausible explanation (Fletcher et al, 1993) of
the recent trends in Sweden. Population-based programmes were
introduced in most counties of Sweden from 1987, with 20 of 26
counties included in 1989 and participation rates among invited
women averaging 81% in the period 1993-95 (Olsson et al, 1995).
The pattern of a rise in incidence in the age groups 50-69 years in
the late 1980s followed by a decline in the 1990s is consistent with
early detection of prevalent cancers through mammography
screening, as earlier demonstrated in the USA (Chu et al, 1996).
We conclude that the recent breast cancer incidence trends in
Sweden are largely reassuring and attributable to the introduction
of population-based screening with mammography. In contrast,
increasing incidence among young women in Norway cannot be
readily explained and deserves, therefore, further investigation.
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